关注
faiez zannad
faiez zannad
Nancy
在 chru-nancy.fr 的电子邮件经过验证
标题
引用次数
引用次数
年份
Heart disease and stroke statistics—2014 update: a report from the American Heart Association
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ...
circulation 129 (3), e28-e292, 2014
66983*2014
2013 ESH/ESC Guidelines for the management of arterial hypertension
G Mancia, R Fagard, K Narkiewicz, J Redon, A Zanchetti, M Böhm, ...
Arterial Hypertension 17 (2), 69-168, 2013
33208*2013
The effect of spironolactone on morbidity and mortality in patients with severe heart failure
B Pitt, F Zannad, WJ Remme, R Cody, A Castaigne, A Perez, J Palensky, ...
New England Journal of Medicine 341 (10), 709-717, 1999
118501999
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 …
Authors/Task Force Members, JJV McMurray, S Adamopoulos, SD Anker, ...
European heart journal 33 (14), 1787-1847, 2012
116162012
Heart disease and stroke statistics 2005 update
American Heart Association
http://www. americanheart. org/statistics/, 2005
8554*2005
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) The Fifth Joint Task Force of the European Society of Cardiology and Other …
European Journal of Preventive Cardiology 19 (4), 585-667, 2012
71352012
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 …
Authors/Task Force Members, K Dickstein, A Cohen-Solal, G Filippatos, ...
European heart journal 29 (19), 2388-2442, 2008
69082008
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
B Pitt, W Remme, F Zannad, J Neaton, F Martinez, B Roniker, R Bittman, ...
New England Journal of Medicine 348 (14), 1309-1321, 2003
62372003
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global …
H Wang, M Naghavi, C Allen, RM Barber, ZA Bhutta, A Carter, DC Casey, ...
The lancet 388 (10053), 1459-1544, 2016
53802016
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with …
Authors/Task Force Members, SG Priori, C Blomström-Lundqvist, ...
Ep Europace 17 (11), 1601-1687, 2015
53042015
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and …
F Cosentino, PJ Grant, V Aboyans, CJ Bailey, A Ceriello, V Delgado, ...
European heart journal 41 (2), 255-323, 2020
44562020
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
CT Trialists
The Lancet 376 (9753), 1670-1681, 2010
4276*2010
Durvalumab after chemoradiotherapy in stage III non–small-cell lung cancer
SJ Antonia, A Villegas, D Daniel, D Vicente, S Murakami, R Hui, T Yokoi, ...
New England Journal of Medicine 377 (20), 1919-1929, 2017
40962017
Cardiovascular and renal outcomes with empagliflozin in heart failure
M Packer, SD Anker, J Butler, G Filippatos, SJ Pocock, P Carson, ...
New England Journal of Medicine 383 (15), 1413-1424, 2020
40812020
Eplerenone in patients with systolic heart failure and mild symptoms
F Zannad, JJV McMurray, H Krum, DJ van Veldhuisen, K Swedberg, H Shi, ...
New England Journal of Medicine 364 (1), 11-21, 2011
37052011
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
MA Pfeffer, JJV McMurray, EJ Velazquez, JL Rouleau, L Køber, ...
New England Journal of Medicine 349 (20), 1893-1906, 2003
33462003
Alogliptin after acute coronary syndrome in patients with type 2 diabetes
WB White, CP Cannon, SR Heller, SE Nissen, RM Bergenstal, GL Bakris, ...
New England journal of medicine 369 (14), 1327-1335, 2013
31222013
Empagliflozin in heart failure with a preserved ejection fraction
SD Anker, J Butler, G Filippatos, JP Ferreira, E Bocchi, M Böhm, ...
New England Journal of Medicine 385 (16), 1451-1461, 2021
31112021
Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial
CM O’Connor, DJ Whellan, KL Lee, SJ Keteyian, LS Cooper, SJ Ellis, ...
Jama 301 (14), 1439-1450, 2009
25092009
Rosuvastatin and cardiovascular events in patients undergoing hemodialysis
BC Fellström, AG Jardine, RE Schmieder, H Holdaas, K Bannister, ...
New England Journal of Medicine 360 (14), 1395-1407, 2009
23222009
系统目前无法执行此操作,请稍后再试。
文章 1–20